MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
También te puede interesar
Ganadores
Últimas noticias sobre criptomonedas
Coinbase to Include HBAR, MANTLE in COIN50 Index for Q4
In an Anthropic simulation test, AI Agents discovered a $4.6 million smart contract vulnerability.
Fed Future Meetings Risk Seeing Increased Disagreements Fueling Market Volatility
Tom Lee: BTC and ETH Risk-Reward Ratio Becoming Quite Attractive
Coinbase is now live with Rayls (RLS) spot trading
Atención al cliente:@weikecs
Cooperación empresarial:@weikecs
Trading cuantitativo y MM:[email protected]
Programa VIP:[email protected]